BIOMERIEUX
BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, and autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret biological test results... ; and other related services such as the installation and maintenance of instruments, user training, and the audit of laboratory workflows. BioMerieux offers diagnostic systems for clinical applications including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples such as blood, saliva, and urine; and for industrial applications including the analysis of microbiological manufacturing such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. BioMerieux were founded in 1963 and is headquartered in Marcy l’Etoile, France. It is a subsidiary of Institut Mérieux.
BIOMERIEUX
Industry:
Biotechnology Health Diagnostics Manufacturing
Founded:
1963-01-01
Address:
Marcy-l'etoile, Rhone-Alpes, France
Country:
France
Website Url:
http://www.biomerieux.com
Total Employee:
101+
Status:
Active
Contact:
(+33) 04 78 87 20 00
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Quantason
Quantason develops bi-modal US/IDUSâ„¢ platform technology for diagnostic imaging and active screening.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-02-07 | Invisible Sentinel | Invisible Sentinel acquired by bioMerieux | 75 M USD |
| 2018-11-09 | SuZhou Hybiome Biomedical Engineering | SuZhou Hybiome Biomedical Engineering acquired by bioMerieux | N/A |
| 2018-04-04 | Astute Medical | Astute Medical acquired by bioMerieux | N/A |
| 2016-06-01 | Hyglos | Hyglos acquired by bioMerieux | N/A |
| 2016-01-05 | Applied Maths | Applied Maths acquired by bioMerieux | N/A |
| 2015-01-22 | CEERAM | CEERAM acquired by bioMerieux | N/A |
| 2014-10-15 | SARL ADVENCIS | SARL ADVENCIS acquired by bioMerieux | N/A |
| 2013-09-03 | BioFire Diagnostics | BioFire Diagnostics acquired by bioMerieux | N/A |
| 2012-07-01 | RTS Life Sciences Ltd. | RTS Life Sciences Ltd. acquired by bioMerieux | N/A |
| 2012-07-01 | RAS Lifesciences | RAS Lifesciences acquired by bioMerieux | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-06-11 | Accellix | bioMerieux investment in Series D - Accellix | 9.5 M USD |
| 2017-12-04 | Qvella Corporation | bioMerieux investment in Series B - Qvella Corporation | 20 M USD |
| 2012-11-15 | Quanterix | bioMerieux investment in Series C - Quanterix | 18.5 M USD |
| 2007-09-18 | AdvanDx | bioMerieux investment in Series C - AdvanDx | 15 M USD |
| 2000-08-01 | MEDoctor | bioMerieux investment in Seed Round - MEDoctor | 3.1 M USD |
Official Site Inspections
http://www.biomerieux.com Semrush global rank: 351.09 K Semrush visits lastest month: 168.74 K
- Host name: 151.101.195.10
- IP address: 151.101.195.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "bioMerieux"
bioMérieux | Pioneering Diagnostics
BioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, …See details»
Our Company - bioMérieux
In 2013, bioMérieux celebrated a major milestone, our 50th anniversary. Our development during these years has been driven by a pioneering spirit and unrelenting commitment to improve …See details»
bioMérieux - Wikipedia
BioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (reagents, instruments, software, ser…See details»
bioMérieux at a glance | Pioneering Diagnostics
We specialize in: Clinical applications: We develop and produce diagnostic solutions that help healthcare professionals quickly and reliably determine a pathology or the source of a contamination and provide them with crucial …See details»
bioMérieux Canada | Pioneering Diagnostics
BioMérieux provides in vitro diagnostic solutions (reagents, instruments, software, services) that determine the source of disease and contamination to improve patient health and ensure consumer safety.See details»
bioMerieux - Crunchbase Company Profile & Funding
BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and …See details»
bioMérieux - The Org
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such …See details»
bioMérieux Canada
Founded in 1992, our subsidiary based its activities on the McDonnell Douglas product with the VITEK® which began in the mid 80’s. The team consisted of three people and its …See details»
Home | Pioneering Diagnostics - bioMérieux Website
BioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% …See details»
bioMérieux - INSTITUT MERIEUX
Personalized services for medical testing and industrial control laboratories. With more than 55 years of experience, bioMérieux is now a major player in the fields of in vitro diagnostics and the fight against infectious diseases. The company …See details»
bioMérieux - Leadership Team - The Org
The Leadership Team at bioMérieux is responsible for steering the company's strategic direction across various functions, including research and development, finance, operations, and …See details»
Our History - bioMérieux
Our History. bioMérieux’s commitment to public health and expertise in biology are rooted in its unique family history.In 1897, Marcel Mérieux, a student of Louis Pasteur, founded an analysis …See details»
bioMérieux - LinkedIn
BioMérieux | 336,436 followers on LinkedIn. Pioneering Diagnostics | Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in ...See details»
Our Company Purpose | Pioneering Diagnostics - bioMérieux …
It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and …See details»
bioMérieux - LinkedIn
BioMérieux | 316,765 followers on LinkedIn. Pioneering Diagnostics | Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 …See details»
Discover CONNECT-UPâ„¢ 2.0 - bioMérieux
CONNECT-UPâ„¢ can eliminate the frustrations associated with manual, labor-intensive data management. When you digitize your data, you can free up the capacity of your skilled team …See details»
| bioMérieux
Once again, bioMerieux and the Emerging and Pandemic Infections Consortium (EPIC) are joining together to host the 2 nd Annual Antimicrobial Resistance (AMR) symposium.. Please …See details»
Accelerate Antimicrobial Stewardship Program Success - bioMérieux
Tiffany's caring style, collaborative nature, and ability to engage critical thinking allows her to work well at all levels in an organization. She has led several initiatives at various institutions that …See details»
About us | bioMérieux - biomerieux.ca
BioMérieux Canada, Inc Henri-Bourassa West, Saint-Laurent, Qué. H4S 1P7 CanadaSee details»